ARMAQ Amarillo Biosciences, Inc ARMAQ
Last Post: 02/09/2014 6:41:01 PM
Board Marks: 0
Posts Today: 0
Board Views Today: 1
Amarillo Biosciences, Inc. (OTCBB: AMARQ) is a specialty biopharmaceutical company developing a patented formulation of interferon-alpha that's given orally in low doses, making it safer and less expensive than current injectable formulations.
Amarillo Biosciences is working with global partners to conduct clinical studies to establish the safety and efficacy of low-dose interferon-alpha given in the form of orally dissolving lozenges to treat a number of significant human diseases, including influenza and hepatitis C.
Amarillo Biosciences is working with global partners to conduct clinical studies to establish the safety and efficacy of low-dose interferon-alpha given in the form of orally dissolving lozenges to treat a number of significant human diseases, including influenza and hepatitis C.
ARMAQ Amarillo Biosciences, Inc (OTCMRKTS: ARMAQ) Stock Message Board
Post
Subject
Author
Posted On
Be the first to post on ARMAQ Amarillo Biosciences, Inc ARMAQ